Use of botulinum toxin in children with cerebral palsy

Stecko Monika, Wawryków Agata, Korabiusz Katarzyna, Fraszczyk Magda, Kordek Agnieszka. Use of botulinum toxin in children with cerebral palsy. Journal of Education, Health and Sport. 2019;9(7):699-702. eISSN 2391-8306. DOI http://dx.doi.org/10.5281/zenodo.3354824 http://ojs.ukw.edu.pl/index.php/johs/article/view/7178 The journal has had 7 points in Ministry of Science and Higher Education parametric evaluation. Part B item 1223 (26/01/2017). 1223 Journal of Education, Health and Sport eISSN 2391-8306 7 © The Authors 2019; This article is published with open access at Licensee Open Journal Systems of Kazimierz Wielki University in Bydgoszcz, Poland Open Access. This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author (s) and source are credited. This is an open access article licensed under the terms of the Creative Commons Attribution Non commercial license Share alike. (http://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non commercial use, distribution and reproduction in any medium, provided the work is properly cited. The authors declare that there is no conflict of interests regarding the publication of this paper. Received: 01.07.2019. Revised: 05.07.2019. Accepted: 30.07.2019. Use of botulinum toxin in children with cerebral palsy Monika Stecko1, Agata Wawryków1, Katarzyna Korabiusz1, Magda Fraszczyk2, Agnieszka Kordek3 1. Pomeranian University of Medical Science, Doctoral Study of the Faculty of Health Sciences, Żołnierska 54, 71-210 Szczecin 2. Pomeranian University of Medical Science, Doctoral Study of the Faculty of Medicine and Dental, ul. Żołnierska 54, 71-210 Szczecin 3. Pomeranian University of Medical Science Neonatal Patology Clinic, Aleja Powstańców Wielkopolskich 72, 70-111 Szczecin Dane autora korespondencyjnego: Monika Stecko mjstecko@gmail.com Abstract Cerebral palsy in children is a syndrome of disorders resulting from damage to the central nervous system in its early development [1]. Damage to the structure of the upper motor neuron during its early development leads to dysfunction of the central motor control system and, consequently, to impairment of the child’s functional development [2,3]. The consequences of damage to the central motor control system include the presence of muscular tension disorders, especially spasticity [4,5]. Botulinum toxin is one of the many pharmacological agents used to reduce spasticity. Botulinum toxin therapy is one of the most effective and currently safest methods for the treatment of spasticity in children [6]. Keywords: cerebral palsy, spasticity, botulinum toxi